Treatments of inhibitors against P-selectin, ROS and Nlrp3 inflammasome pathways ameliorated both ND-induced platelet activation in vitro and ND-induced thrombocytopenia in mice. The gene discussed is NLRP3; the disease is Thrombocytopenia.